Stratatech Makes Strong Addition to Management Team, Russell R. Smestad
MADISON, Wis.--(BUSINESS WIRE)--Stratatech Corp., a privately-held regenerative medicine company, today announced the appointment of Russell R. Smestad as president. Mr. Smestad brings to Stratatech nearly 30 years of executive experience in the biotechnology industry. He will play a key role in shaping and executing the company’s strategy.